Approach to Hyperamylasemia and Hyperlipasemia
10.15279/kpba.2023.28.3.67
- Author:
Se Hee LEE
1
;
Woohyun CHO
;
Min Jae YANG
Author Information
1. Department of Gastroenterology, Ajou University School of Medicine, Suwon, Korea
- Publication Type:Review Article
- From:Korean Journal of Pancreas and Biliary Tract
2023;28(3):67-75
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Hyperamylasemia and hyperlipidemia occur when the amounts of amylase and lipase that enter the blood overweigh the kidney and liver reticuloendothelial system clearance of the enzymes. In normal homeostasis, most of these enzymes are excreted from the apical membrane of the acinar cells into the ductal system of the gland. However, in pathological conditions, this apical exocytosis is blocked, and the leakage of these enzymes at the basolateral membrane is increased. Therefore, these enzymes are released into the bloodstream. Many different pancreatic pathologies and Gullo syndrome can cause this type of leakage in the pancreas. This mechanism can also cause basolateral leakage in other organs that secrete amylase and lipase. In small bowel inflammatory conditions, amylase and lipase are absorbed through the inflamed mucosa and introduced into the bloodstream due to increased vascular permeability. Regardless of the enzymes that enter the blood circulation, several kidney and liver diseases prevent the excretion and metabolism of serum amylase and lipase. When the amylase and lipase are combined with immunoglobulins, they escape normal glomerular filtration due to the development of macroenzymes and accumulate in the blood. These situations related to the clearance of the enzymes are also crucial mechanisms of serum enzyme elevation that should not be overlooked.
